Literature DB >> 16716164

Content of 5-alpha-reductase (type 1 and type 2) mRNA in dermal papillae from the lower abdominal region in women with hirsutism.

P Skałba1, A Dabkowska-Huć, W Kazimierczak, A Samojedny, M P Samojedny, Z Chełmicki.   

Abstract

BACKGROUND: Androgens influence the growth of terminal hair. The dermal papilla contains androgen receptors and the enzymes 5-alpha-reductase types 1 and 2. Both of these enzymes convert testosterone to the more active androgen, 5-alpha-dihydrotestosterone. The male distribution pattern of terminal hair in females is termed hirsutism. It is most common among women with hyperandrogenism; however, it may also affect patients with normal androgen levels (idiopathic hirsutism).
OBJECTIVES: The aim of this study was to assess the expression of 5-alpha-reductase types 1 and 2 mRNA in dermal papillae from the lower abdominal skin in women with hirsutism.
METHODS: The study included 42 subjects, 24 with a diagnosis of polycystic ovary syndrome (PCOS) and 18 with idiopathic hirsutism (IH). In all patients, free serum testosterone was measured.
RESULTS: The mean +/- SD concentration of free serum testosterone was 7.2 +/-5.3 pmol/L in the total group of patients, 10.8 +/- 4.0 pmol/L in patients with PCOS, and 2.5 +/- 1.7 pmol/L in patients with IH. Quantitative analysis was then performed for the mRNA of 5-alpha-reductase types 1 and 2, both of which were found within the dermal papillae from the lower abdominal skin region. The number of mRNA copies/microg of total RNA for 5-alpha-reductase type 1 was statistically significantly higher than that for type 2 in both groups of examined patients. We also demonstrated a positive correlation between the number of mRNA copies/microg of total RNA for 5-alpha-reductase types 1 and 2 and the concentration of free serum testosterone in women with PCOS and IH. Considering all patients together, we found a positive correlation between the number of mRNA copies/microg of total RNA for 5-alpha-reductase type 2 and the concentration of free serum testosterone. There was also a tendency towards a positive correlation between the number of mRNA copies/microg of total RNA for 5-alpha-reductase type 1 and the concentration of free serum testosterone.
CONCLUSION: The results of our study suggest that testosterone increases expression of 5-alpha-reductase types 1 and 2 in dermal papillae from the lower abdominal region in patients with hirsutism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716164     DOI: 10.1111/j.1365-2230.2006.02146.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  3alpha-Hydroxysteroid dehydrogenase type III deficiency: a novel mechanism for hirsutism.

Authors:  Anne Z Steiner; Lilly Chang; Qing Ji; Murad Ookhtens; Andrew Stolz; Richard J Paulson; Frank Z Stanczyk
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

2.  In Vitro and In Vivo Regulation of SRD5A mRNA Expression of Supercritical Carbon Dioxide Extract from Asparagus racemosus Willd. Root as Anti-Sebum and Pore-Minimizing Active Ingredients.

Authors:  Warintorn Ruksiriwanich; Chiranan Khantham; Pichchapa Linsaenkart; Tanakarn Chaitep; Pensak Jantrawut; Chuda Chittasupho; Pornchai Rachtanapun; Kittisak Jantanasakulwong; Yuthana Phimolsiripol; Sarana Rose Sommano; Chaiwat Arjin; Houda Berrada; Francisco J Barba; Korawan Sringarm
Journal:  Molecules       Date:  2022-02-24       Impact factor: 4.411

Review 3.  Hirsutism, Normal Androgens and Diagnosis of PCOS.

Authors:  Poli Mara Spritzer; Lucas Bandeira Marchesan; Betânia Rodrigues Santos; Tayane Muniz Fighera
Journal:  Diagnostics (Basel)       Date:  2022-08-09

4.  Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome.

Authors:  Laura C Torchen; Jan Idkowiak; Naomi R Fogel; Donna M O'Neil; Cedric H L Shackleton; Wiebke Arlt; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2016-03-18       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.